Sandesh Mahatme, EVP, CFO & CBO at Sarepta Therapeutics, Inc. (SRPT), sold 125,000 shares at $125.50 ($15.7M) on 2019-12-13, disclosed to the SEC on 2019-12-17.
Open-market sale of $15.7M SRPT by EVP, CFO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2018-10-26 | $27.5M | — | Filing → |
| SRPT | SELL | 2017-07-21 | $2.0M | — | Filing → |
| SRPT | SELL | 2016-10-19 | $1.5M | — | Filing → |